We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
-1.15%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.4B
AUM Growth
+$334M
(+2.4%)
Cap. Flow
+$578M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
50.45%
Holding
913
New
139
Increased
302
Reduced
176
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGL Energy Partners
NGL
|
+$114M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$112M |
| 3 |
ANDX
Andeavor Logistics LP
ANDX
|
+$65.9M |
| 4 |
Cardinal Health
CAH
|
+$50.7M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$49.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$53.8M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$52.4M |
| 3 |
GRMN
Garmin
GRMN
|
+$50.8M |
| 4 |
The Mosaic Company
MOS
|
+$50.4M |
| 5 |
Valero Energy
VLO
|
+$50.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 58.22% |
| 2 | Healthcare | 2.73% |
| 3 | Financials | 2.71% |
| 4 | Materials | 2.68% |
| 5 | Consumer Discretionary | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
201
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.91M | 0.01% |
48,423
+5,408
| +13% | +$202K |
|
202
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $1.84M | 0.01% |
+37,758
| New | +$1.87M |
|
203
Boeing
BA
$165B
| $1.81M | 0.01% |
6,134
+437
| +8% | +$118K |
|
204
AvalonBay Communities
AVB
$27.1B
| $1.75M | 0.01% |
9,801
-453
| -4% | -$82.2K |
|
205
Digital Realty Trust
DLR
$73.7B
| $1.68M | 0.01% |
14,741
-501
| -3% | -$59K |
|
206
Theravance Biopharma
TBPH
$874M
| $1.67M | 0.01% |
59,951
+6,938
| +13% | +$205K |
|
|
MYOK
207
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.67M | 0.01% |
39,604
+5,179
| +15% | +$200K |
|
208
Equity Residential
EQR
$25.4B
| $1.66M | 0.01% |
26,076
-1,257
| -5% | -$83.9K |
|
209
Ascendis Pharma A/S
ASND
$16.7B
| $1.61M | 0.01% |
40,297
+8,368
| +26% | +$304K |
|
210
Lam Research
LRCX
$382B
| $1.61M | 0.01% |
87,360
+4,880
| +6% | +$95.9K |
|
|
RDUS
211
DELISTED
Radius Health, Inc.
RDUS
| $1.57M | 0.01% |
+49,412
| New | +$1.55M |
|
212
Home Depot
HD
$332B
| $1.54M | 0.01% |
8,108
+3,246
| +67% | +$560K |
|
|
TGE
213
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $1.53M | 0.01% |
59,653
+7,318
| +14% | +$183K |
|
214
Ventas
VTR
$48.9B
| $1.52M | 0.01% |
25,286
-1,141
| -4% | -$72.1K |
|
|
ARNA
215
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.48M | 0.01% |
+43,460
| New | +$1.24M |
|
216
Netflix
NFLX
$292B
| $1.43M | 0.01% |
74,670
+40,160
| +116% | +$773K |
|
217
Boston Properties
BXP
$11B
| $1.42M | 0.01% |
10,954
-495
| -4% | -$62.1K |
|
218
Cognizant
CTSH
$21.5B
| $1.38M | 0.01% |
19,458
+2,120
| +12% | +$155K |
|
|
IPXL
219
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.37M | 0.01% |
82,126
+8,940
| +12% | +$164K |
|
|
DBVT
220
DBV Technologies
DBVT
$807M
| $1.36M | 0.01% |
5,536
+788
| +17% | +$228K |
|
221
Johnson & Johnson
JNJ
$634B
| $1.36M | 0.01% |
9,727
-340,683
| -97% | -$47.5M |
|
222
Microchip Technology
MCHP
$42.8B
| $1.33M | 0.01% |
30,188
+3,578
| +13% | +$162K |
|
223
Dana Inc
DAN
$2.91B
| $1.29M | 0.01% |
40,292
+21,412
| +113% | +$659K |
|
224
Madrigal Pharmaceuticals
MDGL
$12.6B
| $1.27M | 0.01% |
+13,847
| New | +$791K |
|
|
DVAX
225
DELISTED
Dynavax Technologies
DVAX
| $1.26M | 0.01% |
+67,147
| New | +$1.35M |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, ALPS Advisors held 913 positions worth $14.4B, up 2.4% from $14.1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
ALPS Advisors deployed $578M of net new capital in Q4 2017, opening 139 new positions and adding to 302 existing holdings. Its largest new stake was NGL Energy Partners: 9,255,792 shares worth $130M.
By sector, the portfolio is most concentrated in Energy at 58% of assets, down from 58% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was T. Rowe Price, an estimated $53.8M trimmed.
- ALPS Advisors's largest Q4 2017 buy was NGL Energy Partners: 9,255,792 shares worth $130M.
- ALPS Advisors added most to Energy Transfer Partners, L.P. in Q4 2017, an estimated $112M increase.
- ALPS Advisors's biggest Q4 2017 reduction was T. Rowe Price, cutting an estimated $53.8M.
- ALPS Advisors fully exited The Mosaic Company in Q4 2017, selling an estimated $50.4M.
- ALPS Advisors's ten largest holdings make up 50% of its $14.4B portfolio in Q4 2017.
- ALPS Advisors opened 139 new positions and closed 73 in Q4 2017.
- ALPS Advisors's portfolio value rose 2.4% quarter-over-quarter to $14.4B.
Based on ALPS Advisors's 13F filing for Q4 2017, filed 5 Feb 2018.